Ayala Pharmaceuticals Inc (ADXS)

[bill_y]

"There is a major paradigm shift happening now as demonstrated by both the medical and regulatory community. To quote the head of the FDA: In just several decades, gene therapy has gone from being a promising concept to a practical solution to deadly and largely untreatable forms of cancer,” said FDA Commissioner Scott Gottlieb, M.D. “This approval demonstrates the continued momentum of this promising new area of medicine and we’re committed to supporting and helping expedite the development of these products.
So keeping this real IMO SOC for cancer is no longer the gold standard. Facts are we have a safer therapy, does not make patients sick, cost effective compared to $400-$700K for therapy and a survial rate that is equal to or better than SOC. "
very well stated post from nwbo ymb dennis..thank you.